The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 ...

GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks ...

GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...

GlaxoSmithKline (GSK) has filed a patent infringement lawsuit against Moderna in Delaware, accusing the company of using its ...

GSK then acquired that intellectual property ... achieved an astonishing public health success by developing an mRNA vaccine to fight the COVID-19 pandemic in less than a year.

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...